163 related articles for article (PubMed ID: 31351478)
1. Humanized yeast genetic interaction mapping predicts synthetic lethal interactions of FBXW7 in breast cancer.
Kirzinger MWB; Vizeacoumar FS; Haave B; Gonzalez-Lopez C; Bonham K; Kusalik A; Vizeacoumar FJ
BMC Med Genomics; 2019 Jul; 12(1):112. PubMed ID: 31351478
[TBL] [Abstract][Full Text] [Related]
2. Changes in gene expression variability reveal a stable synthetic lethal interaction network in BRCA2-ovarian cancers.
Bueno R; Mar JC
Methods; 2017 Dec; 131():74-82. PubMed ID: 28754563
[TBL] [Abstract][Full Text] [Related]
3. The FBXW7 tumor suppressor inhibits breast cancer proliferation and promotes apoptosis by targeting MTDH for degradation.
Chen X; Li XY; Long M; Wang X; Gao ZW; Cui Y; Ren J; Zhang Z; Liu C; Dong K; Zhang H
Neoplasma; 2018; 65(2):201-209. PubMed ID: 29534580
[TBL] [Abstract][Full Text] [Related]
4. Loss of FBXW7 and accumulation of MCL1 and PLK1 promote paclitaxel resistance in breast cancer.
Gasca J; Flores ML; Giráldez S; Ruiz-Borrego M; Tortolero M; Romero F; Japón MA; Sáez C
Oncotarget; 2016 Aug; 7(33):52751-52765. PubMed ID: 27409838
[TBL] [Abstract][Full Text] [Related]
5. FBXW7 in breast cancer: mechanism of action and therapeutic potential.
Chen S; Leng P; Guo J; Zhou H
J Exp Clin Cancer Res; 2023 Sep; 42(1):226. PubMed ID: 37658431
[TBL] [Abstract][Full Text] [Related]
6. A Drosophila genetic screen for suppressors of S6kinase-dependent growth identifies the F-box subunit Archipelago/FBXW7.
Zahoor MK; Poidevin M; Lecerf C; Garrido D; Montagne J
Mol Genet Genomics; 2019 Jun; 294(3):573-582. PubMed ID: 30656413
[TBL] [Abstract][Full Text] [Related]
7. Employing Cross-Species Approaches to Construct Humanized Genetic Interaction Networks.
Jeusset LM; McManus KJ
Methods Mol Biol; 2021; 2381():115-133. PubMed ID: 34590273
[TBL] [Abstract][Full Text] [Related]
8. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
[TBL] [Abstract][Full Text] [Related]
9. Fbxw7 haploinsufficiency loses its protection against DNA damage and accelerates MNU-induced gastric carcinogenesis.
Jiang Y; Qi X; Liu X; Zhang J; Ji J; Zhu Z; Ren J; Yu Y
Oncotarget; 2017 May; 8(20):33444-33456. PubMed ID: 28422719
[TBL] [Abstract][Full Text] [Related]
10. The WD40 domain of FBXW7 is a poly(ADP-ribose)-binding domain that mediates the early DNA damage response.
Zhang Q; Mady ASA; Ma Y; Ryan C; Lawrence TS; Nikolovska-Coleska Z; Sun Y; Morgan MA
Nucleic Acids Res; 2019 May; 47(8):4039-4053. PubMed ID: 30722038
[TBL] [Abstract][Full Text] [Related]
11. LPRP: A Gene-Gene Interaction Network Construction Algorithm and Its Application in Breast Cancer Data Analysis.
Su L; Meng X; Ma Q; Bai T; Liu G
Interdiscip Sci; 2018 Mar; 10(1):131-142. PubMed ID: 27640171
[TBL] [Abstract][Full Text] [Related]
12. MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells.
Zhao J; Wang Y; Mu C; Xu Y; Sang J
Oncogene; 2017 Aug; 36(35):5023-5034. PubMed ID: 28459460
[TBL] [Abstract][Full Text] [Related]
13. Establishment and analysis of a novel mouse line carrying a conditional knockin allele of a cancer-specific FBXW7 mutation.
Ikenoue T; Terakado Y; Zhu C; Liu X; Ohsugi T; Matsubara D; Fujii T; Kakuta S; Kubo S; Shibata T; Yamaguchi K; Iwakura Y; Furukawa Y
Sci Rep; 2018 Jan; 8(1):2021. PubMed ID: 29386660
[TBL] [Abstract][Full Text] [Related]
14. Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer.
Srihari S; Singla J; Wong L; Ragan MA
Biol Direct; 2015 Oct; 10():57. PubMed ID: 26427375
[TBL] [Abstract][Full Text] [Related]
15. Distinct Interactions of EBP1 Isoforms with FBXW7 Elicits Different Functions in Cancer.
Wang Y; Zhang P; Wang Y; Zhan P; Liu C; Mao JH; Wei G
Cancer Res; 2017 Apr; 77(8):1983-1996. PubMed ID: 28209614
[TBL] [Abstract][Full Text] [Related]
16. miR‑27a promotes human breast cancer cell migration by inducing EMT in a FBXW7‑dependent manner.
Jiang G; Shi W; Fang H; Zhang X
Mol Med Rep; 2018 Dec; 18(6):5417-5426. PubMed ID: 30365154
[TBL] [Abstract][Full Text] [Related]
17. The ubiquitin ligase SCF
Song N; Cao C; Tang Y; Bi L; Jiang Y; Zhou Y; Song X; Liu L; Ge W
J Cell Physiol; 2018 Mar; 233(3):2366-2377. PubMed ID: 28722108
[TBL] [Abstract][Full Text] [Related]
18. FBXW7 expression is associated with prognosis and chemotherapeutic outcome in Chinese patients with gastric adenocarcinoma.
Li MR; Zhu CC; Ling TL; Zhang YQ; Xu J; Zhao EH; Zhao G
BMC Gastroenterol; 2017 May; 17(1):60. PubMed ID: 28464881
[TBL] [Abstract][Full Text] [Related]
19. MiR-223 promotes the doxorubicin resistance of colorectal cancer cells via regulating epithelial-mesenchymal transition by targeting FBXW7.
Ding J; Zhao Z; Song J; Luo B; Huang L
Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):597-604. PubMed ID: 29701752
[TBL] [Abstract][Full Text] [Related]
20. FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy.
Xiao Y; Yin C; Wang Y; Lv H; Wang W; Huang Y; Perez-Losada J; Snijders AM; Mao JH; Zhang P
Mol Oncol; 2018 Jun; 12(6):883-895. PubMed ID: 29633504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
